captopril

Captopril (SA333) is a potent and specific inhibitor of peptidyl-dipeptidase A. It blocks the conversion of angiotensin I to angiotensin II, a vasoconstrictor and important regulator of arterial blood pressure.

Captopril disulfide, a metabolite of Captopril, is a new antihypertensive agent.

Captopril EP Impurity E is an impurity of Captopril. Captopril, also known as SQ-14534, is an orally active angiotensin-converting enzyme (ACE) inhibitor with a thiol group, possessing antihypertensive properties, and an inhibitor constant (IC 50) of 0.025 μM.

Captopril (SQ 14225) hydrochloride is an antihypertensive agent that is a thiol-containing, competitive, orally active angiotensin-converting enzyme (ACE) inhibitor with an IC50 of 0.025 μM, widely used in hypertension and congestive heart failure research. It is also a New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor with an IC50 of 7.9 μM [1] [2] [3].

Captopril EP Impurity D is a useful organic compound for research related to life sciences. The catalog number is T67511 and the CAS number is 56970-78-6.

Captopril EP Impurity B, a degradation product of Captopril (SQ-14534), serves as a thiol-containing, competitive inhibitor of the angiotensin-converting enzyme (ACE), demonstrating oral activity and potent antihypertensive effects with an IC50 value of 0.025 μM [1] [2] [3].

Epicaptopril (SQ 14534) is a derivative of Captopril and serves as an inhibitor of angiotensin-converting enzyme (ACE). It enhances vasodilation dependent on endothelium-derived relaxing factor (EDRF) and acts as a free radical scavenger. This makes it useful in studies related to oxidative stress and cardiovascular diseases caused by free radical damage.

Moveltipril (Moveltipril calcium) is a potent angiotensin-converting enzyme (ACE) inhibitor.Moveltipril is converted to captopril in the body for action.

1,4-Anthraquinone is an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.1,4-